Search - tctmd.com

Displaying 101 - 120 of 126

Sort: Relevancy | Date

Presentation THT 2022

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Presenter: Marat Fudim

February 01, 2022

Presentation THT 2022

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

Presenter: Scott Solomon

February 01, 2022

Presentation THT 2022

SGLT2 Inhibitors in HFrEF and HFpEF

Presenter: Stefan Anker

February 01, 2022

Presentation TVT 2021

Who Are the Ideal Patients for an IASD: HFpEF, HFrEF, RCM, and Beyond…

Presenter: Sanjiv J. Shah

July 22, 2021

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

Presentation TCT 2019

Transcutaneous Pericardictomy for HFpEF

Presenter: Samuel Asirvatham

September 28, 2019

Presentation TCT 2019

Corvia for HFpEF

Presenter: Scott Lilly

September 28, 2019

Presentation TCT 2019

V-Wave for HFrEF and HFpEF

Presenter: Gregg Stone

September 28, 2019

Presentation TCT 2019

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Presenter: Peter Carson

September 28, 2019

Presentation TCT 2019

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Presenter: Felix Mahfoud

September 27, 2019

$Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction Primary results of the PARAGON-HF trial$

Presentation ESC 2019

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

Presenter: Scott D. Solomon

September 01, 2019

Presentation TVT 2019

V-Wave for HFrEF and HFpEF

Presenter: Josep Rodés-Cabau

June 15, 2019

Presentation TVT 2019

Corvia for HFpEF (REDUCE LAP II)

Presenter: Sanjiv Shah

June 15, 2019

Presentation ECHO/IMAGING 2019

HFpEF by Echo Diastolic Function and Strain Imaging

Presenter: James D. Thomas

March 23, 2019

Presentation TCT 2018

Potential Interventions for Hypertensive Patients With HFpEF

Presenter: Mark C. Bates, Bernard J. Gersh, Franz X. Kleber

September 24, 2018

Presentation Controversies and Advances 2017

HFPEF – Echo with Strain vs. MRI T1 Mapping

Presenter: Eric Schelbert

November 17, 2017

Presentation TCT 2017

Potential Interventions for Hypertensive Patients With HFpEF

Presenter: Mark C. Bates, Bernard J. Gersh, William T. Abraham

October 30, 2017

Presentation TCT 2016

Interatrial Shunts in HFpEF: Focus on Corvia

Presenter: Josep Rodés-Cabau, Nir Uriel, Sanjiv Shah

November 01, 2016

Advertisement

Current status of the REBALANCE-HF US FDA randomized feasibility clinical trial in HFpEF

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Putting it into Perspective: Atrial Shunting in the Context of Current Therapies for HFpEF

SGLT2 Inhibitors in HFrEF and HFpEF

Who Are the Ideal Patients for an IASD: HFpEF, HFrEF, RCM, and Beyond…

Echo imaging in HFpEF

Transcutaneous Pericardictomy for HFpEF

Corvia for HFpEF

V-Wave for HFrEF and HFpEF

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator in Patients with HFrEF and HFpEF: The AFR-PRELIEVE Trial

Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction Primary Results of the PARAGON-HF Trial

V-Wave for HFrEF and HFpEF

Corvia for HFpEF (REDUCE LAP II)

HFpEF by Echo Diastolic Function and Strain Imaging

Potential Interventions for Hypertensive Patients With HFpEF

HFPEF – Echo with Strain vs. MRI T1 Mapping

Potential Interventions for Hypertensive Patients With HFpEF

Interatrial Shunts in HFpEF: Focus on Corvia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content